BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/16/2023 4:01:23 AM | Browse: 533 | Download: 1999
Publication Name World Journal of Clinical Cases
Manuscript ID 87696
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Psychiatry
Manuscript Type Case Report
Article Title Multiple therapies relieve long-term tardive dyskinesia in a patient with chronic schizophrenia: A case report
Manuscript Source Unsolicited Manuscript
All Author List Liang Lv, Ping Guo, Min Feng, Yu Fang, Shi-Kai Wang and Huan-Xin Chen
ORCID
Author(s) ORCID Number
Ping Guo http://orcid.org/0000-0002-3735-1993
Shi-Kai Wang http://orcid.org/0000-0002-2321-0524
Funding Agency and Grant Number
Funding Agency Grant Number
Science and Tech Program of Huzhou Municipal No. 2023GYB32
Corresponding Author Shi-Kai Wang, PhD, Chief Physician, Department of Psychiarty, Huzhou The Third People's Hospital Affiliated to Huzhou University, No. 2088 Tiaoxi East Road, Huzhou 313000, Zhejiang Province, China. wang-shikai@163.com
Key Words Tardive dyskinesia; Antipsychotics; Clozapine; Deutetrabenazine; Electroconvulsive therapy; Case report
Core Tip Tardive dyskinesia (TD) is a serious and disabling movement disorder, and its pathogenesis remains unclear. This report describes the treatment of TD caused by risperidone in a schizophrenia patient, which could not be improved by switching to the other second-generation antipsychotics like quetiapine and olanzapine, neither by adjunction with medications like benzodiazepines, ginkgo biloba extract, or antioxidants. Her TD symptoms were relieved remarkably after multiple measures like switching to clozapine, adjunction with deutetrabenazine, and modified electroconvulsive therapy. Multiple measures are therefore recommended for TD treatment.
Publish Date 2023-11-16 04:01
Citation Lv L, Guo P, Feng M, Fang Y, Wang SK, Chen HX. Multiple therapies relieve long-term tardive dyskinesia in a patient with chronic schizophrenia: A case report. World J Clin Cases 2023; 11(32): 7895-7899
URL https://www.wjgnet.com/2307-8960/full/v11/i32/7895.htm
DOI https://dx.doi.org/10.12998/wjcc.v11.i32.7895
Full Article (PDF) WJCC-11-7895-with-cover.pdf
Full Article (Word) WJCC-11-7895.docx